ZAHRA FOROUGHI: Open Payments
NPI 1952896607 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 13 payments from 12 companies in 2025. Trend: 2023 $475 · 2024 $840 · 2025 $1,438
Food & beverage: $1,438
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $242 |
| Gilead Sciences, Inc. | 1 | $130 |
| Corcept Therapeutics | 1 | $126 |
| Janssen Biotech, Inc. | 1 | $125 |
| Incyte Corporation | 1 | $125 |
| Exeltis, USA Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $117 |
| Astellas Pharma US Inc | 1 | $114 |
| Novo Nordisk Inc | 1 | $109 |
| Eisai Inc. | 1 | $103 |
Products named: Epclusa, KRYSTEXXA, Korlym, TREMFYA, Opzelura, AIRSUPRA, Veozah, Leqembi.
Industry payments across FL — which companies pay providers there.
